These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25858021)

  • 1. The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study.
    Shofty B; Mauda-Havakuk M; Weizman L; Constantini S; Ben-Bashat D; Dvir R; Pratt LT; Joskowicz L; Kesler A; Yalon M; Ravid L; Ben-Sira L
    Pediatr Blood Cancer; 2015 Aug; 62(8):1353-9. PubMed ID: 25858021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
    Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
    Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
    Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual outcome following chemotherapy for progressive optic pathway gliomas.
    Shofty B; Ben-Sira L; Freedman S; Yalon M; Dvir R; Weintraub M; Toledano H; Constantini S; Kesler A
    Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP; Leary S; Khanna P; Weiss AH
    Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
    Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
    Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
    Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
    Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring optic chiasmatic-hypothalamic glioma volumetric changes by MRI in children under clinical surveillance or chemotherapy.
    Calixto NC; Simão GN; Dos Santos AC; de Oliveira RS; Junior LGD; Valera ET; Cintra MB; Mello AS
    Childs Nerv Syst; 2019 Jan; 35(1):63-72. PubMed ID: 30078056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated optic nerve gliomas: a multicenter historical cohort study.
    Shofty B; Ben-Sira L; Kesler A; Jallo G; Groves ML; Iyer RR; Lassaletta A; Tabori U; Bouffet E; Thomale UW; Hernáiz Driever P; Constantini S;
    J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
    Packer RJ; Ater J; Allen J; Phillips P; Geyer R; Nicholson HS; Jakacki R; Kurczynski E; Needle M; Finlay J; Reaman G; Boyett JM
    J Neurosurg; 1997 May; 86(5):747-54. PubMed ID: 9126887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
    Rakotonjanahary J; De Carli E; Delion M; Kalifa C; Grill J; Doz F; Leblond P; Bertozzi AI; Rialland X;
    PLoS One; 2015; 10(6):e0127676. PubMed ID: 26098902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X
    PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of carboplatin plus vincristine in an optic pathway glioma.
    Moschovi M; Alexiou GA; Papakonstantopoulou I; Gavra M; Sfakianos G; Prodromou N
    Klin Padiatr; 2010 Nov; 222(6):395-6. PubMed ID: 20806167
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel mutation in the NF1 gene in two siblings with neurofibromatosis type 1 and bilateral optic pathway glioma.
    Kebudi R; Tuncer S; Upadhyaya M; Peksayar G; Spurlock G; Yazici H
    Pediatr Blood Cancer; 2008 Mar; 50(3):713-5. PubMed ID: 17514731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
    Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
    Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.
    Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D
    Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.